Riskpilot← Back to searchSign inGet full accessWALPLICA AS
ASActiveOrg 993046043Malurtveien 1, 1369 StabekkMedical specialists activities · NACE 8622Est. 20081 employees
Revenue 2024
NOK 7,9M
+13% vs 2023
EBITDA margin
44.2%
+33% vs 2023
Equity ratio
3.0%
Financial strength
Net profit 2024
NOK 2,7M
+34% vs 2023
| Revenue | NOK 7,9M | +13% |
| EBITDA | NOK 3,5M | +33% |
| Net profit | NOK 2,7M | +34% |
| Total assets | NOK 3,8M | -25% |
| Equity | NOK 114K | -6% |
| Employees | 1 | — |
Legal name
WALPLICA AS
Org number
993046043
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
20. september 2008
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet og spesialist innen øre-nese-hals & allergi samt annen virksomhet som faller naturlig inn under dette. Videre kjøp/salg og drift av fast eiendom, kjøp/salg av aksjer og andre verdipapirer og hva som står i forbindelse med dette.
Address
Malurtveien 1, 1369 Stabekk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 326 | 6 743 | 6 727 | 6 957 | 7 867 |
| Staff expenses | −885 | −935 | −1 003 | −1 076 | −1 144 |
| EBITDA | 3 223 | 3 341 | 2 793 | 2 618 | 3 475 |
| Depreciation & amort. | −29 | −30 | −27 | −30 | −24 |
| EBIT | 3 193 | 3 311 | 2 766 | 2 588 | 3 451 |
| Net financials | −10 | −6 | −16 | −17 | 0 |
| Profit before tax | 3 184 | 3 305 | 2 750 | 2 570 | 3 452 |
| Tax | 700 | 727 | 605 | 565 | 759 |
| Net profit | 2 483 | 2 578 | 2 145 | 2 005 | 2 693 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 852 | 6 058 | 4 565 | 5 018 | 3 768 |
| Equity | 5 143 | 3 721 | 2 266 | 121 | 114 |
| Long-term debt | 0 | 0 | 0 | 138 | 3 |
| Short-term debt | 1 709 | 2 337 | 2 299 | 4 759 | 3 652 |
| Total debt | 1 709 | 2 337 | 2 299 | 4 897 | 3 654 |
EBITDA margin
44.2%
This company
15.8%
Market median
+180% vs market
20202024
Equity ratio
3.0%
This company
38.2%
Market median
-92% vs market
20202024
Return on equity
2364.4%
This company
18.4%
Market median
+12750% vs market
20202024
Net profit margin
34.2%
This company
8.1%
Market median
+322% vs market
20202024
Asset turnover
2.09×
This company
1.12×
Market median
+87% vs market
20202024
Debt / equity
32.09×
This company
0.62×
Market median
-5076% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RE Deputy Member | Deputy Member | 2008 |
FW Chief Executive Officer | Chief Executive Officer | 2008 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of WALPLICA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ragnhild Elise Walseth | Deputy Member | 0 companies |
| Fridtjof Walseth | Chief Executive Officer | 0 companies |